Athos Capital’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2K Hold
37,052
﹤0.01% 43
2025
Q4
$3K Buy
+37,052
New +$367 ﹤0.01% 36
2025
Q3
Sell
-37,052
Closed -$5K 41
2025
Q2
$5K Hold
37,052
0.01% 36
2025
Q1
$6K Hold
37,052
0.01% 42
2024
Q4
$8K Hold
37,052
﹤0.01% 39
2024
Q3
$14K Hold
37,052
﹤0.01% 40
2024
Q2
$17K Hold
37,052
0.01% 40
2024
Q1
$38K Hold
37,052
0.04% 41
2023
Q4
$56K Hold
37,052
0.06% 39
2023
Q3
$54K Sell
37,052
-6,282
-14% -$1.37K 0.03% 54
2023
Q2
$130 Hold
43,334
0.1% 64
2023
Q1
$46K Hold
43,334
0.03% 82
2022
Q4
$80K Hold
43,334
0.05% 101
2022
Q3
$200K Hold
43,334
0.08% 116
2022
Q2
$161K Hold
43,334
0.06% 132
2022
Q1
$339K Sell
43,334
-49,999
-54% -$48.9K 0.12% 107
2021
Q4
$657K Hold
93,333
0.21% 89
2021
Q3
$920K Hold
93,333
0.22% 98
2021
Q2
$923K Buy
+93,333
New +$95.1K 0.18% 106

Other funds holding PIIIW

Athos Capital's PIIIW Position: Q1 2026 in Review

Athos Capital held its P3 Health Partners Inc Warrant (PIIIW) position steady in Q1 2026 at 37,052 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #43.

Athos Capital first reported a position in PIIIW in Q2 2021 and has held it in 19 quarters since. The position peaked at $923K in Q2 2021. 19 funds tracked by Wall St. Rank hold PIIIW as of Q1 2026.

  • Athos Capital held 37,052 shares of P3 Health Partners Inc Warrant worth $2K as of Q1 2026.
  • Athos Capital left its P3 Health Partners Inc Warrant share count unchanged in Q1 2026.
  • P3 Health Partners Inc Warrant made up ﹤0.01% of Athos Capital's portfolio in Q1 2026, its #43 holding.
  • Athos Capital first reported a position in P3 Health Partners Inc Warrant in Q2 2021 and has held it in 19 quarters since.
  • Athos Capital's P3 Health Partners Inc Warrant position peaked at $923K in Q2 2021.
  • 19 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q1 2026.

Based on Athos Capital's 13F filing for Q1 2026, filed 13 May 2026.